249 related articles for article (PubMed ID: 25876794)
21. Plasminogen activator inhibitor-1 is elevated, but not essential, in the development of bleomycin-induced murine scleroderma.
Matsushita M; Yamamoto T; Nishioka K
Clin Exp Immunol; 2005 Mar; 139(3):429-38. PubMed ID: 15730388
[TBL] [Abstract][Full Text] [Related]
22. Periostin facilitates skin sclerosis via PI3K/Akt dependent mechanism in a mouse model of scleroderma.
Yang L; Serada S; Fujimoto M; Terao M; Kotobuki Y; Kitaba S; Matsui S; Kudo A; Naka T; Murota H; Katayama I
PLoS One; 2012; 7(7):e41994. PubMed ID: 22911870
[TBL] [Abstract][Full Text] [Related]
23. Upregulation of interleukin-13 and its receptor in a murine model of bleomycin-induced scleroderma.
Matsushita M; Yamamoto T; Nishioka K
Int Arch Allergy Immunol; 2004 Dec; 135(4):348-56. PubMed ID: 15564778
[TBL] [Abstract][Full Text] [Related]
24. Diverse expression of N-acetylglucosaminyltransferase V and complex-type β1,6-branched N-glycans in uveal and cutaneous melanoma cells.
Pocheć E; Rydlewska M; Przybyło M; Lityńska A
Acta Biochim Pol; 2015; 62(2):323-8. PubMed ID: 26098720
[TBL] [Abstract][Full Text] [Related]
25. CD109 overexpression ameliorates skin fibrosis in a mouse model of bleomycin-induced scleroderma.
Vorstenbosch J; Al-Ajmi H; Winocour S; Trzeciak A; Lessard L; Philip A
Arthritis Rheum; 2013 May; 65(5):1378-83. PubMed ID: 23436317
[TBL] [Abstract][Full Text] [Related]
26. Disruption of tumor necrosis factor receptor p55 impairs collagen turnover in experimentally induced sclerodermic skin fibroblasts.
Murota H; Hamasaki Y; Nakashima T; Yamamoto K; Katayama I; Matsuyama T
Arthritis Rheum; 2003 Apr; 48(4):1117-25. PubMed ID: 12687556
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of N-acetylglucosaminyltransferases III and V in human melanoma cells. Implications for MCAM N-glycosylation.
Bubka M; Link-Lenczowski P; Janik M; Pocheć E; Lityńska A
Biochimie; 2014 Aug; 103():37-49. PubMed ID: 24726881
[TBL] [Abstract][Full Text] [Related]
28. Predominant expression of N-acetylglucosaminyltransferase V (GnT-V) in neural stem/progenitor cells.
Hamanoue M; Ikeda Y; Ogata T; Takamatsu K
Stem Cell Res; 2015 Jan; 14(1):68-78. PubMed ID: 25524127
[TBL] [Abstract][Full Text] [Related]
29. TRPA1 as a potential factor and drug target in scleroderma: dermal fibrosis and alternative macrophage activation are attenuated in TRPA1-deficient mice in bleomycin-induced experimental model of scleroderma.
Mäki-Opas I; Hämäläinen M; Moilanen E; Scotece M
Arthritis Res Ther; 2023 Jan; 25(1):12. PubMed ID: 36698198
[TBL] [Abstract][Full Text] [Related]
30. Elevated expression of UDP-N-acetylglucosamine: alphamannoside beta1,6 N-acetylglucosaminyltransferase is an early event in hepatocarcinogenesis.
Ito Y; Miyoshi E; Sakon M; Takeda T; Noda K; Tsujimoto M; Ito S; Honda H; Takemura F; Wakasa K; Monden M; Matsuura N; Taniguchi N
Int J Cancer; 2001 Mar; 91(5):631-7. PubMed ID: 11267972
[TBL] [Abstract][Full Text] [Related]
31. A modified murine model of systemic sclerosis: bleomycin given by pump infusion induced skin and pulmonary inflammation and fibrosis.
Liang M; Lv J; Zou L; Yang W; Xiong Y; Chen X; Guan M; He R; Zou H
Lab Invest; 2015 Mar; 95(3):342-50. PubMed ID: 25502178
[TBL] [Abstract][Full Text] [Related]
32. GnT-V expression and metastatic phenotypes in macrophage-melanoma fusion hybrids is down-regulated by 5-Aza-dC: evidence for methylation sensitive, extragenic regulation of GnT-V transcription.
Chakraborty AK; Sousa Jde F; Chakraborty D; Funasaka Y; Bhattacharya M; Chatterjee A; Pawelek J
Gene; 2006 Jun; 374():166-73. PubMed ID: 16556489
[TBL] [Abstract][Full Text] [Related]
33. Immunomodulating role of the JAKs inhibitor tofacitinib in a mouse model of bleomycin-induced scleroderma.
Aung WW; Wang C; Xibei J; Horii M; Mizumaki K; Kano M; Okamura A; Kobayashi T; Matsushita T
J Dermatol Sci; 2021 Mar; 101(3):174-184. PubMed ID: 33451905
[TBL] [Abstract][Full Text] [Related]
34. Formyl Peptide Receptor 2 Activation Ameliorates Dermal Fibrosis and Inflammation in Bleomycin-Induced Scleroderma.
Park GT; Kwon YW; Lee TW; Kwon SG; Ko HC; Kim MB; Kim JH
Front Immunol; 2019; 10():2095. PubMed ID: 31552041
[TBL] [Abstract][Full Text] [Related]
35. Blockade of interleukin-6 receptor alleviates disease in mouse model of scleroderma.
Kitaba S; Murota H; Terao M; Azukizawa H; Terabe F; Shima Y; Fujimoto M; Tanaka T; Naka T; Kishimoto T; Katayama I
Am J Pathol; 2012 Jan; 180(1):165-76. PubMed ID: 22062222
[TBL] [Abstract][Full Text] [Related]
36. CD22 and CD72 contribute to the development of scleroderma in a murine model.
Zhao C; Matsushita T; Ha Nguyen VT; Tennichi M; Fujimoto M; Takehara K; Hamaguchi Y
J Dermatol Sci; 2020 Jan; 97(1):66-76. PubMed ID: 31883832
[TBL] [Abstract][Full Text] [Related]
37. Possible role of apoptosis in the pathogenesis of bleomycin-induced scleroderma.
Yamamoto T; Nishioka K
J Invest Dermatol; 2004 Jan; 122(1):44-50. PubMed ID: 14962088
[TBL] [Abstract][Full Text] [Related]
38. Increased expression of TGF-beta1 in the sclerotic skin in bleomycin-'susceptible' mouse strains.
Oi M; Yamamoto T; Nishioka K
J Med Dent Sci; 2004 Mar; 51(1):7-17. PubMed ID: 15137460
[TBL] [Abstract][Full Text] [Related]
39. Tumor necrosis factor-alpha processing inhibitor-1 inhibits skin fibrosis in a bleomycin-induced murine model of scleroderma.
Terao M; Murota H; Kitaba S; Katayama I
Exp Dermatol; 2010 Jan; 19(1):38-43. PubMed ID: 19758314
[TBL] [Abstract][Full Text] [Related]
40. 17,20S(OH)
Brown Lobbins ML; Scott IO; Slominski AT; Hasty KA; Zhang S; Miller DD; Li W; Kim TK; Janjetovic Z; Patel TS; Myers LK; Postlethwaite AE
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
